Status:
RECRUITING
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Augmented Renal Clearance
Critically Ill
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance
Detailed Description
Single center study in ICU patients with augmented renal clearance comparing glomerular filtration rate (GFR) as measured by iohexol plasma clearance to that measured by creatinine clearance. Primary ...
Eligibility Criteria
Inclusion
- ICU patient
- 24h Creatinine clearance \>130ml/min/1.73m2
- Urinary catheterization
- Affiliation to a social security scheme
Exclusion
- Pregnancy
- CT-scan with contrast media infusion the day of inclusion
- Documented allergy to contrast media
- Patient under guardianship / curatorship
- Patient benefiting from the "State Medical Assistance"
Key Trial Info
Start Date :
September 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04776486
Start Date
September 3 2020
End Date
March 1 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lariboisière Hospital, Surgical ICU
Paris, Île-de-France Region, France, 75010